|
NIP7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79839476643906E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.05659999533248E-08 |
| Normal-vs-Stage2 |
8.096600E-03 |
| Normal-vs-Stage3 |
1.565690E-04 |
| Normal-vs-Stage4 |
4.601000E-03 |
| Stage1-vs-Stage2 |
9.614400E-01 |
| Stage1-vs-Stage3 |
9.866500E-02 |
| Stage1-vs-Stage4 |
2.767600E-01 |
| Stage2-vs-Stage3 |
2.522400E-01 |
| Stage2-vs-Stage4 |
3.143000E-01 |
| Stage3-vs-Stage4 |
9.785000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.959599232355E-11 |
| Normal-vs-AfricanAmerican |
3.28289999995679E-06 |
| Normal-vs-Asian |
1.970790E-01 |
| Caucasian-vs-AfricanAmerican |
1.080640E-01 |
| Caucasian-vs-Asian |
8.985400E-01 |
| AfricanAmerican-vs-Asian |
6.663600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.10209685400787E-11 |
| Normal-vs-Female |
1.30450000024318E-07 |
| Male-vs-Female |
9.897000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.063600E-03 |
| Normal-vs-Extreme_Weight |
1.61709999946247E-07 |
| Normal-vs-Obese |
5.18869999965865E-07 |
| Normal-vs-Extreme_Obese |
7.440200E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.252040E-01 |
| Normal_Weight-vs-Obese |
9.837600E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.103600E-01 |
| Extreme_Weight-vs-Obese |
8.539400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.778600E-01 |
| Obese-vs-Extreme_Obese |
9.044600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.356050E-03 |
| Normal-vs-Age(41-60Yrs) |
8.89999962616628E-10 |
| Normal-vs-Age(61-80Yrs) |
1.20169999506814E-08 |
| Normal-vs-Age(81-100Yrs) |
1.276420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.952000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.066200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.888300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.868200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.495850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.632400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.25639523626842E-11 |
| Normal-VS-Type2 PRCC |
1.961700E-04 |
| Normal-VS-KIRP CIMP |
3.812300E-04 |
| Normal-VS-Unclassified PRCC |
3.823600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.140400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.754270E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.189000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.169880E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.912000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.761600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.960800E-03 |
| Normal-vs-N1 |
1.60429999951361E-07 |
| Normal-vs-N2 |
9.456200E-01 |
| N0-vs-N1 |
9.817500E-03 |
| N0-vs-N2 |
4.367200E-01 |
| N1-vs-N2 |
1.680270E-02 |
|
|
